Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.
about
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA AnalysisPolymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity.Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor.Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients.miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers.Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemia.Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?Advances and challenges in hereditary cancer pharmacogenetics.Pharmacogenetics of drug transporters in modulating imatinib disposition and treatment outcomes in chronic myeloid leukemia & gastrointestinal stromal tumor patients.Pharmacokinetic drug-drug interactions of tyrosine kinase inhibitors: A focus on cytochrome P450, transporters, and acid suppression therapy.Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis.An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure.
P2860
Q26800005-D3604CF6-BEA3-44AC-9210-468A4C4030ECQ33434697-315C3625-9B46-46C3-A6F8-713B8CC981DCQ37367438-2AE4C0A7-64CF-45F4-A0A3-6D86EE9FA72DQ37729245-A4FB1B94-64E5-4DC6-BCC6-0803170085ADQ38602174-2836E3DE-B669-4D95-93D9-66D04F4DF42FQ38826494-D70EB94F-D23E-43A4-A104-9719330A201FQ38888369-D086A8C1-FA96-4490-A32E-E3B4C9B6F641Q38948499-4313F3EE-01DC-4B3E-989F-B5673EAF7B12Q38996487-7F927621-BCBA-47CF-B6D3-935406C8E5A3Q39031326-84D891A9-12D6-4F72-BEE4-5564750B020AQ39068344-3F215928-EEA1-4372-B53B-9BCA6D921858Q40452107-64F7534F-962D-4766-9AB4-65D60126CDAA
P2860
Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Association of ABCG2 polymorph ...... astrointestinal stromal tumor.
@en
Association of ABCG2 polymorph ...... astrointestinal stromal tumor.
@nl
type
label
Association of ABCG2 polymorph ...... astrointestinal stromal tumor.
@en
Association of ABCG2 polymorph ...... astrointestinal stromal tumor.
@nl
prefLabel
Association of ABCG2 polymorph ...... astrointestinal stromal tumor.
@en
Association of ABCG2 polymorph ...... astrointestinal stromal tumor.
@nl
P2093
P2860
P1476
Association of ABCG2 polymorph ...... astrointestinal stromal tumor.
@en
P2093
Baek-Yeol Ryoo
Eun-Young Kim
Jae-Gook Shin
Min-Hee Ryu
Mo Youl Beck
Sang Seop Lee
Yoon-Koo Kang
Young-Soon Na
P2860
P2888
P304
P356
10.1007/S00280-014-2630-6
P50
P577
2014-11-23T00:00:00Z
P6179
1013318346